Endothelial cells and associated innate immune components

Endothelial cells and associated innate immune components represent a complex physiological system rather than a single molecular target. The vascular endothelium serves as a dynamic interface between the blood and underlying tissues, playing a pivotal role in regulating vascular tone, permeability, and the recruitment of immune cells (Nature Reviews Immunology, 2003). These cells express various pattern recognition receptors (PRRs) and adhesion molecules that allow them to sense and respond to pathogens and tissue damage, effectively acting as an integral part of the innate immune system (Frontiers in Immunology, 2018). Associated components include the complement system and innate immune cells like monocytes and neutrophils that interact closely with the endothelial surface. Dysregulation of this system is a hallmark of numerous pathological states, including atherosclerosis, sepsis, and various autoimmune disorders (Journal of Thrombosis and Haemostasis, 2011). Therapeutic strategies often focus on specific molecular pathways within this system, such as cytokine signaling or growth factor pathways, to restore vascular and immune homeostasis. While many drugs target specific molecules within this system, the system as a whole represents a complex biological environment rather than a single druggable target.

Other names

Vascular endotheliumEndothelial-immune interfaceVascular innate immunityEndothelial-leukocyte axis

Drugs interacting with this system typically modulate endothelial activation, inhibit angiogenesis, block leukocyte adhesion and transmigration, or neutralize pro-inflammatory cytokines and complement proteins.